Health · 42 views
Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma
Initial results of the NRG Oncology NRG-GI003 clinical study comparing proton and photon therapy for patients with advanced hepatocellular carcinoma (HCC) indicate that proton therapy did not improve the primary objective of overall…
Summary
Initial results of the NRG Oncology NRG-GI003 clinical study comparing proton and photon therapy for patients with advanced hepatocellular carcinoma (HCC) indicate that proton therapy did not improve the primary objective of overall survival (OS). At the planned interim analysis, the trial was released for reporting after it crossed the futility boundary. Proton therapy also did not improve the trial's secondary endpoints, including progression-free survival (PFS) and local progression (LP). Although fewer grade 3 or higher treatment-related adverse events were observed with proton therapy than with photon therapy (11% vs.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Bayer reaches Roundup settlement that could cost the company billionsContinue reading
- New structures come into view in brain wiring mapsContinue reading
- Cigarettes on silver platters at Bondi ‘clean’ beauty business lip gloss launch referred for investigationContinue reading
- Stress and anxiety are wearing workers down: How to spot your triggers and copeContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow